Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

54 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Long-term clinical outcomes of patients with drug-induced type 1 Brugada electrocardiographic pattern: A nationwide cohort registry study.
Russo V, Caturano A, Migliore F, Guerra F, Francia P, Nesti M, Conte G, Perini AP, Mascia G, Albani S, Marchese P, Santobuono VE, Dendramis G, Rossi A, Attena E, Ghidini AO, Sciarra L, Palamà Z, Baldi E, Romeo E, D'Onofrio A, Nigro G; IBRYD Study Group. Russo V, et al. Among authors: attena e. Heart Rhythm. 2024 May;21(5):555-561. doi: 10.1016/j.hrthm.2024.01.015. Epub 2024 Jan 18. Heart Rhythm. 2024. PMID: 38242222 Free article.
Subcutaneous versus transvenous implantable cardioverter-defibrillator among drug-induced type-1 ECG pattern Brugada syndrome: a propensity score matching analysis from IBRYD study.
Russo V, Caturano A, Guerra F, Migliore F, Mascia G, Rossi A, Nesti M, Santobuono VE, Attena E, Tola G, Sciarra L, Conte G, Paoletti Perini A, Francia P, Dendramis G, Palamà Z, Albani S, Ottonelli Ghidini A, Calò L, D'Onofrio A, Baldi E; IBRYD Study Group. Russo V, et al. Among authors: attena e. Heart Vessels. 2023 May;38(5):680-688. doi: 10.1007/s00380-022-02204-x. Epub 2022 Nov 24. Heart Vessels. 2023. PMID: 36418560 Free PMC article.
Correction to: Subcutaneous versus transvenous implantable cardioverter-defibrillator among drug-induced type-1 ECG pattern Brugada syndrome: a propensity score matching analysis from IBRYD study.
Russo V, Caturano A, Guerra F, Migliore F, Mascia G, Rossi A, Nesti M, Santobuono VE, Attena E, Tola G, Sciarra L, Conte G, Paoletti Perini A, Francia P, Dendramis G, Palamà Z, Albani S, Ottonelli Ghidini A, Calò L, D'Onofrio A, Baldi E; IBRYD Study Group. Russo V, et al. Among authors: attena e. Heart Vessels. 2023 May;38(5):689-690. doi: 10.1007/s00380-022-02228-3. Heart Vessels. 2023. PMID: 36607387 Free PMC article. No abstract available.
Electrophysiological Study Prognostic Value and Long-Term Outcome in Drug-Induced Type 1 Brugada Syndrome: The IBRYD Study.
Russo V, Pafundi PC, Caturano A, Dendramis G, Ghidini AO, Santobuono VE, Sciarra L, Notarstefano P, Rucco MA, Attena E, Floris R, Romeo E, Sarubbi B, Nigro G, D'Onofrio A, Calò L, Nesti M. Russo V, et al. Among authors: attena e. JACC Clin Electrophysiol. 2021 Oct;7(10):1264-1273. doi: 10.1016/j.jacep.2021.03.010. Epub 2021 Apr 28. JACC Clin Electrophysiol. 2021. PMID: 33933405 Free article.
Clinical profile of direct oral anticoagulants versus vitamin K anticoagulants in octogenarians with atrial fibrillation: a multicentre propensity score matched real-world cohort study.
Russo V, Attena E, Di Maio M, Mazzone C, Carbone A, Parisi V, Rago A, D'Onofrio A, Golino P, Nigro G. Russo V, et al. Among authors: attena e. J Thromb Thrombolysis. 2020 Jan;49(1):42-53. doi: 10.1007/s11239-019-01923-9. J Thromb Thrombolysis. 2020. PMID: 31385163 Clinical Trial.
54 results